Effect modification of the association of cumulative exposure and cancer risk by intensity of exposure and time since exposure cessation: a flexible method applied to cigarette smoking and lung cancer in the SYNERGY Study

American Journal of Epidemiology
Jelle VlaanderenRoel Vermeulen

Abstract

The indiscriminate use of the cumulative exposure metric (the product of intensity and duration of exposure) might bias reported associations between exposure to hazardous agents and cancer risk. To assess the independent effects of duration and intensity of exposure on cancer risk, we explored effect modification of the association of cumulative exposure and cancer risk by intensity of exposure. We applied a flexible excess odds ratio model that is linear in cumulative exposure but potentially nonlinear in intensity of exposure to 15 case-control studies of cigarette smoking and lung cancer (1985-2009). Our model accommodated modification of the excess odds ratio per pack-year of cigarette smoking by time since smoking cessation among former smokers. We observed negative effect modification of the association of pack-years of cigarette smoking and lung cancer by intensity of cigarette smoke for persons who smoked more than 20-30 cigarettes per day. Patterns of effect modification were similar across individual studies and across major lung cancer subtypes. We observed strong negative effect modification by time since smoking cessation. Application of our method in this example of cigarette smoking and lung cancer demonstrated ...Continue Reading

References

Jan 1, 1992·American Journal of Industrial Medicine·T J Smith
Mar 1, 1995·Environmental Health Perspectives·R W HornungR Roscoe
Mar 29, 2001·International Journal of Cancer. Journal International Du Cancer·L SimonatoP Zambon
Oct 25, 2002·American Journal of Epidemiology·Karen LeffondréBernard Rachet
Mar 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Jay H Lubin, Neil E Caporaso
Jun 16, 2006·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Paolo BoffettaAage Andersen
Jun 6, 2007·American Journal of Epidemiology·Jay H LubinJan M Zielinski
Mar 13, 2008·Environmental Health Perspectives·David B Richardson
Sep 17, 2008·Environmental Health Perspectives·Frank E SpeizerSumi Mehta
Oct 28, 2008·American Journal of Epidemiology·David B Richardson
Jan 21, 2009·Statistical Methods in Medical Research·Thomas Hamelryck
Aug 5, 2010·Radiation Research·Kyoji FurukawaKiyohiko Mabuchi
Nov 3, 2010·American Journal of Respiratory and Critical Care Medicine·Ann C OlssonKurt Straif
Aug 25, 2011·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Maria N TimofeevaPaul Brennan
Nov 5, 2011·International Journal of Cancer. Journal International Du Cancer·Beate PeschThomas Brüning
Apr 27, 2012·Journal of the National Cancer Institute·Margaret R SpitzNeil E Caporaso
Sep 26, 2012·Epidemiology·David B RichardsonBryan Langholz

❮ Previous
Next ❯

Citations

Dec 21, 2013·American Journal of Epidemiology·Duncan C Thomas
Feb 17, 2015·Risk Analysis : an Official Publication of the Society for Risk Analysis·Suresh H MoolgavkarRoger McClellan
May 9, 2014·Critical Reviews in Toxicology·Suresh H MoolgavkarDavid G Hoel
Jan 4, 2015·Human Molecular Genetics·Florence GuidaMarc Chadeau-Hyam
Dec 18, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Eduardo De StefaniMaría Mendilaharsu
Sep 11, 2019·American Journal of Epidemiology·Beate PeschThomas Brüning
Aug 23, 2019·Journal of Neurology, Neurosurgery, and Psychiatry·Susan PetersUNKNOWN Euro-MOTOR consortium
Apr 25, 2020·American Journal of Respiratory and Critical Care Medicine·Calvin GeRoel Vermeulen
Jul 20, 2016·Head & Neck·Lisa A PetersonUNKNOWN University of Michigan Head and Neck Specialized Program of Research Excellence Program
Nov 24, 2017·Risk Analysis : an Official Publication of the Society for Risk Analysis·Suresh H MoolgavkarEdmund C Lau
Apr 14, 2017·Epidemiologic Reviews·Megan A Clarke, Corinne E Joshu
Nov 20, 2020·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·Rudolf Kaaks, Stefan Delorme
Oct 12, 2018·Cancer Prevention Research·John P PierceKaren Messer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Jay H Lubin, Neil Caporaso
© 2021 Meta ULC. All rights reserved